• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Patient-reported outcome measures in definitive chemoradiation for non-small cell lung cancer.

作者信息

Voong Khinh Ranh, Feliciano Josephine L

机构信息

Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA.

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA.

出版信息

Transl Lung Cancer Res. 2020 Feb;9(1):4-7. doi: 10.21037/tlcr.2019.10.06.

DOI:10.21037/tlcr.2019.10.06
PMID:32206547
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7082294/
Abstract
摘要

相似文献

1
Patient-reported outcome measures in definitive chemoradiation for non-small cell lung cancer.非小细胞肺癌根治性放化疗中患者报告的结局指标
Transl Lung Cancer Res. 2020 Feb;9(1):4-7. doi: 10.21037/tlcr.2019.10.06.
2
Long-Term Survival after Salvage Surgery for Local Failure after Definitive Chemoradiation Therapy for Locally Advanced Non-small Cell Lung Cancer.局部晚期非小细胞肺癌根治性放化疗后局部复发行挽救性手术后的长期生存情况
Thorac Cardiovasc Surg. 2018 Mar;66(2):135-141. doi: 10.1055/s-0037-1606597. Epub 2017 Oct 9.
3
Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?对于局部晚期非小细胞肺癌，在进行根治性放化疗后出现局部复发时，是否应考虑挽救性手术？
J Cardiothorac Surg. 2016 Jan 19;11:9. doi: 10.1186/s13019-016-0396-0.
4
The Addition of Chemotherapy to Radiation Therapy Improves Survival in Elderly Patients with Stage III Non-Small Cell Lung Cancer.放化疗联合治疗可提高 III 期老年非小细胞肺癌患者的生存率。
J Thorac Oncol. 2018 Mar;13(3):426-435. doi: 10.1016/j.jtho.2017.11.135. Epub 2018 Jan 8.
5
Salvage Surgery After Definitive Chemoradiotherapy for Non-small Cell Lung Cancer.非小细胞肺癌根治性放化疗后的挽救性手术
Semin Thorac Cardiovasc Surg. 2017;29(2):233-241. doi: 10.1053/j.semtcvs.2017.02.001. Epub 2017 Feb 24.
6
[Lung Resection after Definitive and Neo-Adjuvant Chemoradiation for Stage IIIA/B Locally Advanced Non-Small Cell Lung Cancer: a Retrospective Analysis].[ⅢA/B期局部晚期非小细胞肺癌根治性及新辅助放化疗后的肺切除术：一项回顾性分析]
Zentralbl Chir. 2018 Jun;143(3):307-315. doi: 10.1055/a-0584-7886. Epub 2018 Jun 22.
7
Pulmonary resections following prior definitive chemoradiation therapy are associated with acceptable survival.根治性放化疗后进行肺切除术与可接受的生存相关。
Eur J Cardiothorac Surg. 2013 Jul;44(1):e66-70. doi: 10.1093/ejcts/ezt184. Epub 2013 Apr 4.
8
Definitive treatment patterns and survival in stage II non-small cell lung cancer.局限期 II 期非小细胞肺癌的明确治疗模式和生存情况。
Lung Cancer. 2018 Oct;124:135-142. doi: 10.1016/j.lungcan.2018.07.035. Epub 2018 Jul 24.
9
Neoadjuvant chemoradiation and surgery improves survival outcomes compared with definitive chemoradiation in the treatment of stage IIIA N2 non-small-cell lung cancer.在 IIIA 期 N2 非小细胞肺癌的治疗中，与根治性放化疗相比，新辅助放化疗联合手术可改善生存结局。
Eur J Cardiothorac Surg. 2015 Nov;48(5):684-90; discussion 690. doi: 10.1093/ejcts/ezu504. Epub 2015 Jan 6.
10
Prospective assessment of demographic characteristics associated with worse health related quality of life measures following definitive chemoradiation in patients with locally advanced non-small cell lung cancer.对局部晚期非小细胞肺癌患者进行根治性放化疗后，与健康相关生活质量较差测量指标相关的人口统计学特征的前瞻性评估。
Transl Lung Cancer Res. 2019 Aug;8(4):332-339. doi: 10.21037/tlcr.2019.08.21.

引用本文的文献

1
New developments in locally advanced nonsmall cell lung cancer.局部晚期非小细胞肺癌的新进展。
Eur Respir Rev. 2021 May 5;30(160). doi: 10.1183/16000617.0227-2020. Print 2021 Jun 30.

本文引用的文献

1
Prospective assessment of demographic characteristics associated with worse health related quality of life measures following definitive chemoradiation in patients with locally advanced non-small cell lung cancer.对局部晚期非小细胞肺癌患者进行根治性放化疗后，与健康相关生活质量较差测量指标相关的人口统计学特征的前瞻性评估。
Transl Lung Cancer Res. 2019 Aug;8(4):332-339. doi: 10.21037/tlcr.2019.08.21.
2
Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer: A Phase 2 Trial.局部消融治疗寡转移性非小细胞肺癌后使用帕博利珠单抗：一项2期试验
JAMA Oncol. 2019 Sep 1;5(9):1283-1290. doi: 10.1001/jamaoncol.2019.1449.
3
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study.寡转移非小细胞肺癌患者的局部巩固治疗与维持治疗或观察：多机构、Ⅱ期、随机研究的长期结果。
J Clin Oncol. 2019 Jun 20;37(18):1558-1565. doi: 10.1200/JCO.19.00201. Epub 2019 May 8.
4
Cost-Effectiveness of Web-Based Patient-Reported Outcome Surveillance in Patients With Lung Cancer.基于网络的肺癌患者报告结局监测的成本效益分析。
J Thorac Oncol. 2019 Jun;14(6):1012-1020. doi: 10.1016/j.jtho.2019.02.005. Epub 2019 Feb 15.
5
Cancer statistics, 2019.癌症统计数据，2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
6
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.度伐利尤单抗化疗和放疗后用于 III 期非小细胞肺癌的总生存。
N Engl J Med. 2018 Dec 13;379(24):2342-2350. doi: 10.1056/NEJMoa1809697. Epub 2018 Sep 25.
7
Consolidative Local Ablative Therapy Improves the Survival of Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Activating Mutation Treated With First-Line EGFR-TKIs.局部巩固性消融治疗改善携带 EGFR 激活突变的初治同步寡转移 NSCLC 患者的生存
J Thorac Oncol. 2018 Sep;13(9):1383-1392. doi: 10.1016/j.jtho.2018.05.019. Epub 2018 May 29.
8
Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.局限性转移性非小细胞肺癌的巩固性放疗：一项 2 期随机临床试验。
JAMA Oncol. 2018 Jan 11;4(1):e173501. doi: 10.1001/jamaoncol.2017.3501.
9
Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.调强放射治疗技术对局部晚期非小细胞肺癌的影响：NRG肿瘤学RTOG 0617随机临床试验的二次分析
J Clin Oncol. 2017 Jan;35(1):56-62. doi: 10.1200/JCO.2016.69.1378. Epub 2016 Oct 31.
10
Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial.非小细胞肺癌患者放射剂量递增研究的生活质量分析：放射治疗肿瘤学组 0617 随机临床试验的二次分析。
JAMA Oncol. 2016 Mar;2(3):359-67. doi: 10.1001/jamaoncol.2015.3969.